{"id":75439,"date":"2025-02-26T08:09:31","date_gmt":"2025-02-26T16:09:31","guid":{"rendered":"https:\/\/www.qualityhealth.org\/bree\/?page_id=75439"},"modified":"2026-01-27T17:25:17","modified_gmt":"2026-01-28T01:25:17","slug":"oncology","status":"publish","type":"page","link":"https:\/\/www.qualityhealth.org\/bree\/implementation-guide-home-page\/oncology\/","title":{"rendered":"Oncology"},"content":{"rendered":"

[vc_row overlay_dotted=”” el_id=”oncology-guidelines-row”][vc_column][vc_tta_tour style=”outline” shape=”square” color=”black” spacing=”20″ active_section=”1″ no_fill_content_area=”true” title=”Cervical Cancer Screening” el_id=”cervical-cancer-tour”][vc_tta_section title=”Guideline Information” tab_id=”1705966727195-a28de328-fca5″][vc_column_text]<\/p>\n

Guideline title: Cervical Cancer Screening Report and Guidelines<\/strong><\/h4>\n

Publication Status:<\/strong> Active<\/p>\n

Date of publication<\/strong>: 2021<\/p>\n

Date of last evidence search: <\/strong>2021<\/p>\n

Scope: <\/strong>HPV Vaccine; cervical cancer screening; abnormal result follow-up;\u00a0 colposcopy<\/p>\n

Methods:<\/strong> Current guidelines and literature review and expert consensus<\/p>\n

Description: <\/strong>This guideline\u2019s goal is to decrease the incidence of mortality and morbidity from cervical cancer. Appropriate prevention through HPV vaccination, appropriate screening, and structured follow-up to abnormal results are mechanisms to achieve this goal. The guideline also recognizes that the capacity of a delivery site to conduct population management activities such as follow-up will vary. Treatment and\/or management of cervical cancer is out of scope of these guidelines.<\/span>[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”Read On-line” tab_id=”1705966727874-18975572-73e3″][vc_column_text]<\/p>\n

Cervical Cancer Screening Report and Guidelines<\/a><\/h3>\n

[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”Resources and Tools” tab_id=”1705966750129-1c80fcf4-02b3″][vc_toggle title=”Resources and Tools”]WA Breast, Cervical and Colon Health Program\u00a0<\/a><\/p>\n

WA DOH Cervical Cancer\u00a0<\/a><\/p>\n

UPSTF Cervical Cancer Screening<\/a><\/p>\n

Patient Decision Aid: Pap test: Should I have colposcopy if my Pap test shows minor cell changes?<\/a><\/p>\n

Patient Decision Aid: Making Choices: A decision aid for women with a mildly abnormal pap smear<\/a><\/p>\n

If You Have It, Check It: Overcoming Barriers to Cervical Cancer Screening with Patients on the Female-to-Male Transgender Spectrum Training<\/a>[\/vc_toggle][\/vc_tta_section][vc_tta_section title=”Metrics and Evaluation Tools” tab_id=”1705966779912-60aa95d5-0f89″][vc_column_text css=””]<\/p>\n

\n
\n
\n
\n

To support health system improvement the Bree Collaborative has created score cards that are designed to help measure progress on the implementation of our guidelines. These were developed in collaboration with subject matter experts and are aligned across audience types (such as state agencies, health plans, providers, community organizations, employers, etc.)<\/p>\n

To use our score cards, find the audience type, or types, that is closest to your organization or area of improvement work and download the document. There may be more than one \u201caudience\u201d type that is relevant. For example, large health systems may want to track progress at both the organizational level and the individual practitioner level.<\/p>\n

Score cards are also aligned with the Bree Collaboratives\u2019 self-report data collection efforts. Organizations are not required to report, however anyone can submit data to help track system wide progress, measure their progress against others, and to be eligible for implementation awards.<\/p><\/div>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_toggle title=”Delivery Sites and Health Systems”]Health System Evaluation Score Card<\/a>[\/vc_toggle][vc_toggle title=”Health Plans”]Health Plan Evaluation Score Card<\/a>[\/vc_toggle][vc_toggle title=”Health Care Providers”]Health Provider Evaluation Score Card[\/vc_toggle][vc_toggle title=”Washington State Agencies”]Washington State Health Care Authority<\/p>\n

Washington State Department of Health[\/vc_toggle][vc_toggle title=”Washington State Legislature”][\/vc_toggle][vc_toggle title=”Health Care Purchasers”][\/vc_toggle][\/vc_tta_section][vc_tta_section title=”Examples of Implementation – IN DEVELOPMENT” tab_id=”1705966867060-a2d63556-24fa”][\/vc_tta_section][vc_tta_section title=”Workgroup Members” tab_id=”1739899357890-a0b52c43-c472″][vc_column_text css=””]<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n
Name<\/strong><\/td>\nTitle<\/strong><\/td>\nOrganization<\/strong><\/td>\n<\/tr>\n
Chair: Laura Kate Zaichkin, MPH<\/td>\nDirector of Health Plan Performance and Strategy<\/td>\nSEIU 775 Benefits Group<\/td>\n<\/tr>\n
Virginia Arnold, DNP ARNP<\/td>\nProvider<\/td>\nNeighborcare Health at Pike Place Market<\/td>\n<\/tr>\n
Diana Buist, PhD, MPH<\/td>\nSenior Investigator and Director of Research and Strategic Partnerships<\/td>\nKaiser Permanente Washington Health Research Institute<\/td>\n<\/tr>\n
LuAnn Chen, MD, MHA, FAAFP<\/td>\nSenior Medical Director<\/td>\nCommunity Health Plan of Washington<\/td>\n<\/tr>\n
Colleen Haller, MPH<\/td>\nManager, Care Improvement & Clinical Integration<\/td>\nCommunity Health Plan of Washington<\/td>\n<\/tr>\n
Beth Kruse, CNM<\/td>\nMidwife<\/td>\nPublic Health Seattle King
\nCounty<\/td>\n<\/tr>\n
Jordann Loehr, MD<\/td>\nObstetrics and Gynecology<\/td>\nToppenish Medical-Dental Clinic<\/td>\n<\/tr>\n
Constance Mao, MD<\/td>\nAssociate Professor Emeritus, Obstetrics and Gynecology<\/td>\nUniversity of Washington School of Medicine<\/td>\n<\/tr>\n
Sophia Shaddy, MD, Sandra White, MD<\/td>\nPathologist<\/td>\nCellNetix Pathology<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”Awards” tab_id=”1739899358710-33ba9e5b-fbe6″][vc_column_text css=””]Award winners for Best Practices in Cervical Cancer Screening:<\/p>\n

\"\"<\/p>\n